Alcohol and drug use among clients receiving internet-delivered cognitive behavior therapy for anxiety and depression in a routine care clinic - Demographics, use patterns, and prediction of treatment completion and outcomes.
Alcohol
Anxiety
Depression
Drugs
Internet-delivered cognitive behavior therapy
OTU, Online Therapy Unit
Substance use
Journal
Internet interventions
ISSN: 2214-7829
Titre abrégé: Internet Interv
Pays: Netherlands
ID NLM: 101631612
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
received:
18
03
2021
revised:
25
11
2021
accepted:
13
12
2021
entrez:
6
1
2022
pubmed:
7
1
2022
medline:
7
1
2022
Statut:
epublish
Résumé
Research shows that alcohol and drug use among mental health clients is common and has the potential to negatively impact treatment outcomes. Internet-delivered cognitive behavior therapy (ICBT) as a treatment for anxiety and depression is on the rise, but little is known about the prevalence of alcohol and drug use among clients and how this use affects treatment completion and outcomes. The objective of the current study was to explore the prevalence of alcohol and drug use among clients in ICBT for depression and anxiety, and to investigate the impact of alcohol and drug use on treatment completion and symptom outcomes. Data was collected from 1155 clients who participated in two randomized ICBT trials for depression and anxiety, conducted in a routine care clinic. Thirty-five individuals reporting severe substance use when applying to the trials were excluded. Demographic variables, and alcohol and drug use were measured at screening, and measures of depression and anxiety were administered at pre- and post-treatment. Four out of five clients reported having used alcohol in the past year, while one in five reported having used drugs in the past year. Around a third of clients had reported either problematic alcohol use, drug problems, or both. The analyses showed that drug problems, and combined alcohol and drug problems were negatively associated with treatment completion, but neither alcohol nor drug use had an impact on depression and anxiety outcomes. Alcohol and drug problems are likely to be present among a large proportion of patients using ICBT for anxiety and depression. This may not be a barrier to treatment benefit, at least when those with severe alcohol and drug problems have been excluded.
Sections du résumé
BACKGROUND
BACKGROUND
Research shows that alcohol and drug use among mental health clients is common and has the potential to negatively impact treatment outcomes. Internet-delivered cognitive behavior therapy (ICBT) as a treatment for anxiety and depression is on the rise, but little is known about the prevalence of alcohol and drug use among clients and how this use affects treatment completion and outcomes.
OBJECTIVE
OBJECTIVE
The objective of the current study was to explore the prevalence of alcohol and drug use among clients in ICBT for depression and anxiety, and to investigate the impact of alcohol and drug use on treatment completion and symptom outcomes.
MATERIAL AND METHODS
METHODS
Data was collected from 1155 clients who participated in two randomized ICBT trials for depression and anxiety, conducted in a routine care clinic. Thirty-five individuals reporting severe substance use when applying to the trials were excluded. Demographic variables, and alcohol and drug use were measured at screening, and measures of depression and anxiety were administered at pre- and post-treatment.
RESULTS
RESULTS
Four out of five clients reported having used alcohol in the past year, while one in five reported having used drugs in the past year. Around a third of clients had reported either problematic alcohol use, drug problems, or both. The analyses showed that drug problems, and combined alcohol and drug problems were negatively associated with treatment completion, but neither alcohol nor drug use had an impact on depression and anxiety outcomes.
CONCLUSIONS
CONCLUSIONS
Alcohol and drug problems are likely to be present among a large proportion of patients using ICBT for anxiety and depression. This may not be a barrier to treatment benefit, at least when those with severe alcohol and drug problems have been excluded.
Identifiants
pubmed: 34987979
doi: 10.1016/j.invent.2021.100490
pii: S2214-7829(21)00130-5
pmc: PMC8693421
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100490Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that appear to have influenced the work reported in this paper.
Références
Addict Sci Clin Pract. 2017 Jan 4;12(1):2
pubmed: 28049515
Psychol Assess. 2012 Mar;24(1):66-76
pubmed: 21744971
JAMA Psychiatry. 2017 Apr 1;74(4):351-359
pubmed: 28241179
Clin Psychol Rev. 2000 Mar;20(2):149-71
pubmed: 10721495
Depress Anxiety. 2002;15(4):183-5
pubmed: 12112724
Cogn Behav Ther. 2011;40(1):34-44
pubmed: 21337213
Schizophr Res. 2004 Apr 1;67(2-3):157-66
pubmed: 14984874
Internet Interv. 2018 Apr 06;12:181-188
pubmed: 30135782
Addict Behav. 2012 Jan;37(1):11-24
pubmed: 21981788
J Clin Med. 2019 Aug 17;8(8):
pubmed: 31426460
Drug Alcohol Depend. 2015 Sep 1;154:1-13
pubmed: 26072219
Compr Psychiatry. 2005 Nov-Dec;46(6):405-16
pubmed: 16275207
Lancet Psychiatry. 2019 Dec;6(12):1068-1080
pubmed: 31630984
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Alcohol Clin Exp Res. 2007 Jul;31(7):1208-17
pubmed: 17451397
Depress Anxiety. 2018 Sep;35(9):851-860
pubmed: 29999576
Arch Gen Psychiatry. 2011 Aug;68(8):800-7
pubmed: 21810645
Arch Gen Psychiatry. 2004 Aug;61(8):807-16
pubmed: 15289279
Alcohol Res Health. 2004-2005;28(1):5-16
pubmed: 19006986
BMC Med Res Methodol. 2017 Dec 6;17(1):162
pubmed: 29207961
BMJ Open. 2019 Nov 10;9(11):e028236
pubmed: 31712330
J Affect Disord. 2016 Dec;206:169-173
pubmed: 27475887
J Affect Disord. 2017 Apr 15;213:168-171
pubmed: 28242498
Cochrane Database Syst Rev. 2015 Mar 05;(3):CD011565
pubmed: 25742186
J Affect Disord. 2016 Dec;206:321-330
pubmed: 27426694
J Anxiety Disord. 2015 Oct;35:88-102
pubmed: 26422822
Clin Psychol Rev. 2005 Sep;25(6):734-60
pubmed: 16042994
Drug Alcohol Depend. 2013 Dec 1;133(2):338-43
pubmed: 23906994
Internet Interv. 2018 Jul 26;13:108-115
pubmed: 30206525
Alcohol Clin Exp Res. 2011 Apr;35(4):695-702
pubmed: 21223306
Curr Opin Psychiatry. 2008 Jan;21(1):14-8
pubmed: 18281835
Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):345-59
pubmed: 20633738
Am J Addict. 2014 Nov-Dec;23(6):570-5
pubmed: 25164533
Am J Addict. 2015 Mar;24(2):98-104
pubmed: 25644860
Am J Drug Alcohol Abuse. 2018;44(6):578-586
pubmed: 29723083
Depress Anxiety. 2007;24(6):392-8
pubmed: 17096386
Psychosomatics. 1996 Nov-Dec;37(6):518-22
pubmed: 8942202
J Subst Abuse Treat. 2015 Jun;53:52-9
pubmed: 25682718
Ont Health Technol Assess Ser. 2019 Feb 19;19(6):1-199
pubmed: 30873251
Internet Interv. 2020 Aug 31;22:100347
pubmed: 32995303
Eur Addict Res. 2005;11(1):22-31
pubmed: 15608468
J Med Internet Res. 2020 Aug 31;22(8):e18100
pubmed: 32865497
Alcohol Clin Exp Res. 2003 Jul;27(7):1132-41
pubmed: 12878919
Soc Psychiatry Psychiatr Epidemiol. 2016 Jan;51(1):129-40
pubmed: 26260950
PLoS One. 2014 Aug 14;9(8):e104615
pubmed: 25122509
Alcohol Clin Exp Res. 2007 Feb;31(2):185-99
pubmed: 17250609
Alcohol Clin Exp Res. 2010 Aug;34(8):1417-24
pubmed: 20491736
Compr Psychiatry. 1999 Jan-Feb;40(1):44-50
pubmed: 9924877
Internet Interv. 2021 Apr 20;25:100394
pubmed: 33996510